Nanobiotix S.A. NBTX

Latest FY: 2025 Healthcare Biotechnology
Market Price $40.66
Market Cap $1.97B
P/E Ratio N/A
Quick Peer Compare (Healthcare):
Revenue (FY 2025) ↑512.3% YoY
$29.64M
3-Yr CAGR: 27.4%
Net Income ↑64.8% YoY
-$23.96M
Net Margin: -80.8%
Free Cash Flow
N/A
FCF Yield: N/A
EPS (Diluted)
N/A
Basic: N/A
Return on Equity Efficiency
N/A
ROA: -35.4%
⚡ N/A due to negative equity (share buybacks or other)

📊 Multi-Year Historical Performance & Trends

Financial Performance History Revenue, Net Income & Free Cash Flow
Margins Trend (%) Gross, Operating & Net Margins
Balance Sheet Strength Cash, Debt & Equity
Cash Flow Generation Operating Cash Flow vs CapEx vs FCF

📈 Year-over-Year (YoY) Growth History (NBTX)

All monetary values in millions ($M)
⚠️ YoY Data Quality Alert
  • FY 2019: Revenue YoY (+2090.5%) is identical to Gross Profit YoY (+2090.5%). Verify the underlying Revenue and Gross Profit values for FY 2019 and FY 2018.
  • FY 2020: Revenue YoY (-1.1%) is identical to Gross Profit YoY (-1.1%). Verify the underlying Revenue and Gross Profit values for FY 2020 and FY 2019.
Fiscal Year Revenue Revenue YoY Gross Profit Net Income Net Inc YoY Diluted EPS EPS YoY Div / Sh Div Yield Op. Cash Flow Free Cash Flow FCF YoY
FY 2017
FY 2018 $0.1M $0.1M $-30.3M
FY 2019 $2.5M +2,090.5% $2.5M $-50.9M -67.8%
FY 2020 $2.5M -1.1% $2.5M $-33.6M +34.0%
FY 2021 $7.9M +215.3% $7.6M $-47.1M -40.1%
FY 2022 $14.3M +80.9% $8.5M $-57.0M -21.2%
FY 2023 $30.1M +109.8% $22.1M $-39.7M +30.4%
FY 2024 $-7.2M -123.9% $-68.1M -71.6%
FY 2025 $29.6M +512.3% $19.2M $-24.0M +64.8%
$

Valuation

Market Price $40.66
Market Cap $1.97B
Enterprise Value $2.01B
P/E Ratio N/A
P/B Ratio N/A
FCF Yield N/A
Dividend Yield 0.00%
Shares Outstanding 48,410,068
%

Profitability & Margins

Gross Margin 64.93%
Operating Margin -36.49%
Net Margin -80.83%
Return on Equity (ROE) N/A (Negative Equity)
Return on Assets (ROA) -35.36%
Asset Turnover 0.44x
Revenue 3-Yr CAGR 27.42%
🛡️

Financial Health & Liquidity

Current Ratio 1.09
Cash Ratio 0.92
Debt / Equity -1.128
Debt / Assets 1.407
Cash & Equivalents $52.75M
Total Debt $95.32M
Book Value / Share $-1.75
💧

Cash Flow Efficiency

Operating Cash Flow N/A
Capital Expenditures (CapEx) $538.00K
Free Cash Flow N/A
OCF / Revenue N/A
FCF / Revenue N/A
FCF 3-Yr CAGR N/A
🏷️

Per Share Metrics

EPS (Diluted) N/A
EPS (Basic) N/A
Dividends / Share N/A
Book Value / Share $-1.75
EPS YoY Growth N/A
🏛️

Balance Sheet (FY 2025)

Total Assets $67.76M
Total Liabilities $152.24M
Stockholders' Equity -$84.48M
Current Assets $62.75M
Current Liabilities $57.51M